A new ultraspecific urine test for prostate cancer is available. The test improves upon PSA test, increases ability to differentiate high-risk prostate tumors, and may cut unnecessary biopsies.
Read More
Scouting for new instrumentation, decision-support software, equipment, or diagnostic tests? It’s all in here.
Read More
The test is being released in a phased approach beginning with an early-access, clinical-experience program to a limited number of medical and scientific thought leaders, followed by an expanded-access program later in the year.
Read More
Molecular biology is continuing to revolutionize disease diagnosis. Modern molecular tests based on the detection of nucleic acids (ie, DNA and RNA) offer considerable advantages over traditional methods of pathogen detection.
Read More
The research has implications for risk of hereditary and sporadic disease.
Read More